Cargando…
DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence
When the cell cycle is arrested, growth-promoting pathways such as mTOR (Target of Rapamycin) drive cellular senescence, characterized by cellular hyper-activation, hypertrophy and permanent loss of the proliferative potential. While arresting cell cycle, p53 (under certain conditions) can inhibit t...
Autores principales: | Leontieva, Olga V., Blagosklonny, Mikhail V. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034181/ https://www.ncbi.nlm.nih.gov/pubmed/21212465 |
Ejemplares similares
-
The choice between p53-induced senescence and quiescence is
determined in part by the mTOR pathway
por: Korotchkina, Lioubov G., et al.
Publicado: (2010) -
While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts
por: Leontieva, Olga V., et al.
Publicado: (2017) -
Gerosuppression by pan-mTOR inhibitors
por: Leontieva, Olga V., et al.
Publicado: (2016) -
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion
por: Leontieva, Olga V, et al.
Publicado: (2013) -
Yeast-like chronological senescence in mammalian cells: phenomenon, mechanism and pharmacological suppression
por: Leontieva, Olga V., et al.
Publicado: (2011)